TPW
DGX icon

Talon Private Wealth’s Quest Diagnostics DGX Stock Holding History

Talon Private Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74K Buy
+18
New +$3.53K ﹤0.01% 210
2025
Q2 		$305K Buy
1,698
+202
+14% +$35.1K 0.04% 144
2025
Q1 		$253K Sell
1,496
-869
-37% -$143K 0.03% 157
2024
Q4 		$357K Buy
+2,365
New +$368K 0.07% 103

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Talon Private Wealth's DGX Position: Q2 2026 in Review

Talon Private Wealth opened a new position in Quest Diagnostics (DGX) in Q2 2026: 18 shares worth $3.74K. The stake represents ﹤0.01% of the portfolio and ranks #210 among its holdings. This is a return to the name: Talon Private Wealth previously reported a position in DGX as recently as Q2 2025.

Talon Private Wealth first reported a position in DGX in Q4 2024 and has held it in 4 quarters since. The position peaked at $357K in Q4 2024. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Talon Private Wealth held 18 shares of Quest Diagnostics worth $3.74K as of Q2 2026.
  • Quest Diagnostics was a new Talon Private Wealth position in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Talon Private Wealth's portfolio in Q2 2026, its #210 holding.
  • Talon Private Wealth first reported a position in Quest Diagnostics in Q4 2024 and has held it in 4 quarters since.
  • Talon Private Wealth's Quest Diagnostics position peaked at $357K in Q4 2024.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Talon Private Wealth's 13F filing for Q2 2026, filed 11 Sep 2026.